Hello all looking for some references/articles for our upcoming SOP changes.
We are rewriting our pediatrics and neonatal transfusion SOPs; specifically MTP and plasma use. What articles out there state we should not use A plasma for pediatrics and or neonates (or reversed, what articles DO say we can use this). As well as FP5, pediatric populations vs neonates. In searching for some answers, it appears many facilities do not use A plasma for pediatrics <18 years as well as FP5. I would like to be able to cite the articles in our SOP to reflect our decisions.